(Q28169144)

English

Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographics

scientific article (publication date: July 2004)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographics (English)

0 references

0 references

1 reference

C J Hawkey

1

0 references

M Farkouh

series ordinal

2

0 references

X Gitton

series ordinal

3

0 references

E Ehrsam

series ordinal

4

0 references

J Huels

series ordinal

5

0 references

P Richardson

series ordinal

6

0 references

language of work or name

English

0 references

publication date

1 July 2004

0 references

published in

Alimentary Pharmacology & Therapeutics

0 references

volume

20

0 references

issue

1

0 references

page(s)

51-63

0 references

cites work

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02026.X

retrieved

21 April 2017

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

Reporting of 6-month vs 12-month data in a clinical trial of celecoxib

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02026.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2036.2004.02026.X

0 references

Fatcat ID

release_vl47fbdtxbbzpdastkuslojc74

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/vl47fbdtxbbzpdastkuslojc74

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed ID

15225171

0 references

ResearchGate publication ID

8483678

0 references

(Q28169144)

Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographics

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)